Wang Da-ming, Chen Hai-bo, Liu Jia-chun, Liu Fang, Wang Li-jun, Lu Jun
Department of Neurosurgery, Beijing Hospital, Beijing 100730, China.
Chin Med J (Engl). 2008 Jun 20;121(12):1068-71.
Vertebrobasilar artery stenosis is an important cause of ischemic posterior circulation strokes. This study aimed at evaluating the safety and efficacy of treatment including conservative therapy alone and conservative plus endovascular therapy for elderly patients with symptomatic vertebrobasilar artery stenosis.
Patients older than 60 years with symptomatic vertebrobasilar artery stenosis (> or = 50%) confirmed by cerebral angiography were enrolled. All of them were treated with medical therapy and some with additional stent-assisted angioplasty (the stenting subgroup). Their clinical, imaging, intervention and follow-up data were analyzed.
One hundred and seventeen consecutive elderly patients (100 men, mean age (68.1 +/- 5.1) years) were enrolled and followed up for a mean time of 28.4 months; 81.7% of them were symptomatically resolved or improved; a stroke rate of 5.1% and a stroke-related death rate of 1.7% were found among them during the hospitalization and follow-up. In the stenting subgroup, 78 balloon expandable stents were employed in the 70 patients with a technical success rate of 98.7% and the mean degree of stenosis was significantly reduced from (81.7 +/- 14.3)% before stenting to (8.3 +/- 4.2)% after stenting (P < 0.001). Four (5.7%) periprocedural strokes occurred, of whom two led to death within 30 days after the procedure. During the follow-up (mean 27.7 months), sixty of the surviving 68 patients in the stenting subgroup were symptomatically resolved or improved. Only one (1.5%) posterior circulation stroke occurred, while duplex ultrasound scan of 34 patients demonstrated 10 (29.4%) in-stent restenosis.
Appropriate utilization of conservative therapy alone and conservative plus endovascular therapy may improve short-term clinical outcomes for elderly patients with symptomatic vertebrobasilar artery stenosis. Furthermore, stent-assisted angioplasty is technically feasible and relatively safe in elderly patients.
椎基底动脉狭窄是缺血性后循环卒中的重要病因。本研究旨在评估单纯保守治疗以及保守治疗加血管内治疗对有症状的老年椎基底动脉狭窄患者的安全性和疗效。
纳入年龄大于60岁、经脑血管造影证实有症状的椎基底动脉狭窄(≥50%)的患者。所有患者均接受药物治疗,部分患者接受额外的支架辅助血管成形术(支架置入亚组)。分析他们的临床、影像学、干预及随访数据。
连续纳入117例老年患者(100例男性,平均年龄(68.1±5.1)岁),平均随访28.4个月;其中81.7%的患者症状得到缓解或改善;住院及随访期间卒中发生率为5.1%,卒中相关死亡率为1.7%。在支架置入亚组中,70例患者使用了78枚球囊扩张支架,技术成功率为98.7%,平均狭窄程度从支架置入前的(81.7±14.3)%显著降至支架置入后的(8.3±4.2)%(P<0.001)。围手术期发生4例(5.7%)卒中,其中2例在术后30天内死亡。随访期间(平均27.7个月),支架置入亚组中68例存活患者中有60例症状得到缓解或改善。仅发生1例(1.5%)后循环卒中,而34例患者的双功超声扫描显示10例(29.4%)有支架内再狭窄。
合理应用单纯保守治疗以及保守治疗加血管内治疗可改善有症状的老年椎基底动脉狭窄患者的短期临床结局。此外,支架辅助血管成形术在老年患者中技术上可行且相对安全。